Synthesis and bioactivity of Luffarin I

Mar Drugs. 2015 Apr 20;13(4):2407-23. doi: 10.3390/md13042407.

Abstract

The first synthesis of Luffarin I, sesterterpenolide isolated from sponge Luffariella geometrica, has been accomplished from commercially available sclareol. The key strategy involved in this synthesis is the diastereoselective reduction of an intermediate ketone. Luffarin I against human solid tumor cell lines showed antiproliferative activities (GI50) in the range 12-17 μM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Butyrolactone / analogs & derivatives*
  • 4-Butyrolactone / chemical synthesis
  • 4-Butyrolactone / chemistry
  • 4-Butyrolactone / pharmacology
  • Animals
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Australia
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Diterpenes / chemistry
  • Furans / chemical synthesis*
  • Furans / chemistry
  • Furans / pharmacology
  • Humans
  • Indicators and Reagents / chemistry
  • Molecular Conformation
  • Molecular Structure
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Osmolar Concentration
  • Pacific Ocean
  • Porifera / chemistry
  • Sesterterpenes / chemical synthesis*
  • Sesterterpenes / chemistry
  • Sesterterpenes / pharmacology
  • Stereoisomerism

Substances

  • Antineoplastic Agents
  • Diterpenes
  • Furans
  • Indicators and Reagents
  • Sesterterpenes
  • luffarin I
  • sclareol
  • 4-Butyrolactone